Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Dividends Calendar
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team
Pressemeddelelse

Nordstrahl, a leading radiotherapy practice in Germany, selects C-RAD’s innovative SGRT solution

C-Rad

C-RAD announces today a new order for the Catalyst+HD™ and Sentinel 4DCT™ from Nordstrahl, a leading radiotherapy practice in Nuremberg, Germany. The order includes multiple systems, along with a multiyear service agreement

The Nordstrahl practice, led by Dr. Clemens Albrecht and Dr. Christian Grehn, is renowned for providing the highest quality patient care and advanced treatment techniques. The addition of C-RAD's state-of-the-art radiotherapy systems to its portfolio is expected to further enhance the practice's capabilities and enable it to provide the most accurate and efficient treatments possible.

Sophie Taubner, lead physicist of Nordstrahl commented “We are excited to improve the quality of treatment with the C-RAD system. We will provide a much more precise and marker-less positioning of the patient from beginning to the end of radiotherapy.“

The order, which has a value, before taxes, of approximately 8,3 MSEK for C-RAD, includes the complete software suite, including modules for Respiratory Gating, Patient Setup & Positioning, and Motion Monitoring, as well as a dedicated solution for the Varian Halcyon systems. Delivery and installation are expected to commence before the end of the year.

"We are delighted to have been selected by Nordstrahl to provide our innovative radiation therapy solutions," said Cecilia de Leeuw, CEO and President of C-RAD AB. "Our advanced technology will enable the Nordstrahl practice to provide the highest levels of precision, accuracy, and safety to their patients, while also streamlining their workflows and increasing efficiency."

For further information:


Cecilia de Leeuw, CEO, +46 (0)18 751 33 22, investors@c-rad.com

About C-RAD


C-RAD develops surface-guided imaging solutions for radiation therapy to allow highly accurate dose delivery to the tumor, and at the same time, to protect healthy tissue from unwanted exposure. Using high-speed 3D cameras combined with augmented reality, C-RAD supports the initial patient setup process and monitors the patient's motion during treatment to ensure high confidence, an efficient workflow, and improved accuracy. C-RAD monitors the patient's motion without the use of tattoos or additional imaging dose, to deliver the highest level of patient safety and comfort.

C-RAD. Inspiring excellence in cancer treatment.

C-RAD AB is listed on NASDAQ Stockholm.

For more information on C-RAD, please visit http://www.c-rad.com

Attachments


Nordstrahl, a leading radiotherapy practice in Germany, selects C-RAD’s innovative SGRT solution

Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.
  • Latest
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Dividends Calendar
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team